2alpha-hydroxyheinsiagenin A 3-O-[beta-D-glucopyranosyl-(1→2)]-[beta-D-glucopyranosyl-(1→4)]-beta-D-glucopyranoside - Compound Card

2alpha-hydroxyheinsiagenin A 3-O-[beta-D-glucopyranosyl-(1→2)]-[beta-D-glucopyranosyl-(1→4)]-beta-D-glucopyranoside

Select a section from the left sidebar

2alpha-hydroxyheinsiagenin A 3-O-[beta-D-glucopyranosyl-(1→2)]-[beta-D-glucopyranosyl-(1→4)]-beta-D-glucopyranoside

Structure
Zoomed Structure
  • Family: Plantae - Rubiaceae
  • Kingdom: Plantae
  • Class: Saponin
    • Subclass: Triterpenoid Saponin
Canonical Smiles OC[C@H]1O[C@@H](O[C@H]2[C@H](O)C[C@]34[C@H](C2(C)C)CC[C@@H]2[C@@]4(C3)CC[C@]3([C@@]2(C)CC[C@@H]3[C@@H](/C=C/C=C(/C(=O)N[C@@H]2C(=O)O[C@@H]([C@@H]2C)C)\C)C)C)[C@@H]([C@H]([C@@H]1O[C@@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O)O)O[C@@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O
InChI InChI=1S/C54H85NO20/c1-23(10-9-11-24(2)45(67)55-34-25(3)26(4)69-46(34)68)27-14-15-52(8)33-13-12-32-50(5,6)44(28(59)18-54(32)22-53(33,54)17-16-51(27,52)7)75-49-43(74-48-40(65)38(63)36(61)30(20-57)71-48)41(66)42(31(21-58)72-49)73-47-39(64)37(62)35(60)29(19-56)70-47/h9-11,23,25-44,47-49,56-66H,12-22H2,1-8H3,(H,55,67)/b10-9+,24-11+/t23-,25+,26-,27-,28-,29-,30-,31-,32+,33+,34+,35-,36-,37+,38+,39-,40-,41+,42-,43-,44+,47+,48+,49+,51-,52+,53+,54-/m1/s1
InChIKey YJKGYFLFQBFYCU-YXUCCVFCSA-N
Formula C54H85NO20
HBA 20
HBD 12
MW 1068.26
Rotatable Bonds 14
TPSA 333.31
LogP -0.57
Number Rings 9
Number Aromatic Rings 0
Heavy Atom Count 75
Formal Charge 0
Fraction CSP3 0.89
Exact Mass 1067.57
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Mussaenda luteola Rubiaceae Plantae 43523

Showing of synonyms

  • Mohamed S.M, Bachkeet E.Y, et al. (2015). Potent antitrypanosomal triterpenoid saponins from Mussaenda luteola. Fitoterapia, 2015, 107, 114-121. [View] [PubMed]
Pubchem: 134693007

No compound-protein relationship available.

Structure

SMILES: O1CCC(C1=O)NC(=O)C=CC=CCC(CC2)C(CC3)C2C4CCC(C5(C346)C6)CC(CC5)OC(C7OC8CCCCO8)OCC(C7)OC9CCCCO9

Level: 4

Mol. Weight: 1068.26 g/mol

Structure

SMILES: O1CCC(C1=O)NC(=O)C=CC=CCC(CC2)C(CC3)C2C4CCC(C5(C346)C6)CC(CC5)OC(OCCC7)C7OC8CCCCO8

Level: 3

Mol. Weight: 1068.26 g/mol

Structure

SMILES: O1CCC(C1=O)NC(=O)C=CC=CCC(CC2)C(CC3)C2C4CCC(C5(C346)C6)CC(CC5)OC(OC7)CCC7OC8CCCCO8

Level: 3

Mol. Weight: 1068.26 g/mol

Structure

SMILES: C1CCC(CC2)C1C3CCC(C4(C235)C5)CC(CC4)OC(C6OC7CCCCO7)OCC(C6)OC8CCCCO8

Level: 3

Mol. Weight: 1068.26 g/mol

Structure

SMILES: O1CCC(C1=O)NC(=O)C=CC=CCC(CC2)C(CC3)C2C4CCC(C5(C346)C6)CC(CC5)OC7CCCCO7

Level: 2

Mol. Weight: 1068.26 g/mol

Structure

SMILES: C1CCC(CC2)C1C3CCC(C4(C235)C5)CC(CC4)OC(OCCC6)C6OC7CCCCO7

Level: 2

Mol. Weight: 1068.26 g/mol

Structure

SMILES: C1CCC(CC2)C1C3CCC(C4(C235)C5)CC(CC4)OC(OC6)CCC6OC7CCCCO7

Level: 2

Mol. Weight: 1068.26 g/mol

Structure

SMILES: O1CCCCC1OC2CC(COC2)OC3CCCCO3

Level: 2

Mol. Weight: 1068.26 g/mol

Structure

SMILES: O1CCC(C1=O)NC(=O)C=CC=CCC(CC2)C(CC3)C2C4CCC(C5(C346)C6)CCCC5

Level: 1

Mol. Weight: 1068.26 g/mol

Structure

SMILES: C1CCC(CC2)C1C3CCC(C4(C235)C5)CC(CC4)OC6CCCCO6

Level: 1

Mol. Weight: 1068.26 g/mol

Structure

SMILES: C1OCCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1068.26 g/mol

Structure

SMILES: C1CCCC(C1(C234)C2)CCC3C5C(CC4)CCC5

Level: 0

Mol. Weight: 1068.26 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 1068.26 g/mol

Structure

SMILES: O=C1CCCO1

Level: 0

Mol. Weight: 1068.26 g/mol

Antitrypanosomal

Absorption

Caco-2 (logPapp)
-6.39
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
316381.590
Human Oral Bioavailability 50%
Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
41348260.49

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.840
Plasma Protein Binding
87.77
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
0.920
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Safe
Bioconcentration Factor
-961658.980
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-1.310
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
4.050
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Toxic
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-75045093277.910
Rat (Acute)
3.910
Rat (Chronic Oral)
161.230
Fathead Minnow
94728423.070
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Toxic
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
8440486713.570
Hydration Free Energy
-2.920
Log(D) at pH=7.4
-4678.910
Log(P)
1.71
Log S
-2.82
Log(Vapor Pressure)
-277940778.92
Melting Point
213.45
pKa Acid
-2025143.29
pKa Basic
-16274.59
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
ADP-ribosylation factor 1 P84080 ARF1_BOVIN Bos taurus 3 0.9054
Trichothecene 15-O-acetyltransferase TRI3 Q9C1B7 TRI3_FUSSP Fusarium sporotrichioides 3 0.8476
Photosynthetic reaction center cytochrome c subunit P07173 CYCR_BLAVI Blastochloris viridis 3 0.7947
Phosphotriesterase Q5KZU5 Q5KZU5_GEOKA Geobacillus kaustophilus 3 0.7418
Transcriptional activator, LuxR/UhpA family of regulators Q7NQP7 Q7NQP7_CHRVO Chromobacterium violaceum 3 0.7134
Chitinase Q54276 Q54276_SERMA Serratia marcescens 3 0.7099
Photosynthetic reaction center cytochrome c subunit P07173 CYCR_BLAVI Blastochloris viridis 3 0.7073

Download SDF